Benedict Choi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Benedict Choi has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Albertas Navickas
Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, USA
1 shared publication- Arjun Scott Nanda
Academic Laboratory of Medical Genetics, Addenbrooke’s Treatment Centre, Addenbrooke’s Hospital, Cambridge, UK
1 shared publication Brian Woo
Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, USA
1 shared publication- Bruce Culbertson
Integrated Program in Cellular, Molecular, and Biomedical Studies, Columbia University Vagelos College of Physicians and Surgeons, New York, USA
1 shared publication - Daniel Markett
Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, USA
1 shared publication - Hani Goodarzi
Department of Biochemistry and Biophysics, University of California, San Francisco, USA
1 shared publication
Latest Publications
- Open Access
- 11 May 2023
- Published by Springer Nature in Nature Cancer
- Vol. 4 (5) , 682-698
A sense-antisense RNA interaction promotes breast cancer metastasis via regulation of NQO1 expression
Antisense RNAs are ubiquitous in human cells, yet their role is largely unexplored. Here we profiled antisense RNAs in the MDA-MB-231 breast cancer cell line and its highly lung metastatic derivative. We identified one antisense RNA that drives cancer progression by upregulating the redox enzyme NADPH quinone dehydrogenase 1 (NQO1), and named it NQO1-AS. Knockdown of either NQO1 or NQO1-AS reduced lung colonization in a mouse model, and investigation into the role of NQO1 indicated that it is broadly protective against oxidative damage and ferroptosis. Breast cancer cells in the lung are dependent on this pathway, and this dependence can be exploited therapeutically by inducing ferroptosis while inhibiting NQO1. Together, our findings establish a role for NQO1-AS in the progression of breast cancer by regulating its sense mRNA post-transcriptionally. Because breast cancer predominantly affects females, the disease models used in this study are of female origin and the results are primarily applicable to females.
- 11 May 2023
- Published by Springer Nature in Nature Cancer
- Vol. 4 (5) , 682-698
Open AccessA sense-antisense RNA interaction promotes breast cancer metastasis via regulation of NQO1 expression
Antisense RNAs are ubiquitous in human cells, yet their role is largely unexplored. Here we profiled antisense RNAs in the MDA-MB-231 breast cancer cell line and its highly lung metastatic derivative. We identified one antisense RNA that drives cancer progression by upregulating the redox enzyme NADPH quinone dehydrogenase 1 (NQO1), and named it NQO1-AS. Knockdown of either NQO1 or NQO1-AS reduced lung colonization in a mouse model, and investigation into the role of NQO1 indicated that it is broadly protective against oxidative damage and ferroptosis. Breast cancer cells in the lung are dependent on this pathway, and this dependence can be exploited therapeutically by inducing ferroptosis while inhibiting NQO1. Together, our findings establish a role for NQO1-AS in the progression of breast cancer by regulating its sense mRNA post-transcriptionally. Because breast cancer predominantly affects females, the disease models used in this study are of female origin and the results are primarily applicable to females.